PTGER3: Prostaglandin E2 receptor EP3 subtype
Receptor for prostaglandin E2 (PGE2).
- Drugs that act on it: 2
- Approved: 1
- In phases 1 to 3: 1
- Sponsors: 1
Who is on it, and how far along
Every drug ChEMBL records acting on PTGER3, by the furthest stage it has reached for any use, coloured by modality.
How to read this
Each mark is one drug. Columns run from approved to phase 1; hover or tap a mark for its sponsor, modality and open trials, and click it to open the drug.
- Small molecule 2
The landscape
Every drug acting on it, furthest along first. The sponsor is the US application holder where there is one, else the industry lead sponsor of most of its registered trials.| MisoprostolBoxed warning | Approved | Pfizer | Small molecule | AgonistProstanoid EP3 receptor agonist | 44 |
| Sepetaprost | Phase 3 | — | Small molecule | AgonistProstanoid EP3 receptor agonist | 0 |
Open trials
The most recently posted recruiting or ongoing trials naming each drug (up to 8 a drug), 8 in all, from ClinicalTrials.gov.Diseases most associated with it
Open Targets association score, 0 to 1; all associations- Hemorrhage
- 0.58
- Osteoarthritis
- 0.58
- Duodenal ulcer
- 0.46
- Peptic ulcer disease
- 0.46
- Pregnancy
- 0.39
- Uterine corpus leiomyoma
- 0.38
- Pain
- 0.37
- Neurodegenerative disease
- 0.37
- Gastroesophageal reflux disease
- 0.37
Genes and related targets
Complexes and families that share a gene with this target- Genes
- PTGER3
- Related
- Prostaglandin E2 receptor
Drugs, mechanisms, furthest stage (max phase) and modality (molecule type) are from ChEMBL CHEMBL3710, ChEMBL 37, fetched 2026-11-18 (CC BY-SA 3.0). Sponsors are the US application holder (Drugs@FDA) for approved drugs with a US page, else the industry lead sponsor of the most of the drug's ClinicalTrials.gov trials. Open trials are recruiting or ongoing studies naming the drug as an intervention on ClinicalTrials.gov, checked daily; this page as of 2026-11-18. Gene name, function (UniProt P43115, CC BY 4.0) and disease associations are from Open Targets (CC0). ChEMBL and Open Targets